Hyperpolarized Imaging in Diagnosing Participants With Glioma
Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
This pilot trial studies the side effects of hyperpolarized carbon C 13 pyruvate magnetic
resonance imaging (MRI) in diagnosing participants with glioma. Diagnostic procedures, such
as hyperpolarized carbon C 13 pyruvate MRI, may help find and diagnose glioma.